4//SEC Filing
Capponi Vincent 4
Accession 0001104659-24-107141
CIK 0001175151other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 9:00 PM ET
Size
8.5 KB
Accession
0001104659-24-107141
Insider Transaction Report
Form 4
Capponi Vincent
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-04+100,000→ 100,000 totalExercise: $1.19Exp: 2034-10-04→ Common Stock (100,000 underlying) - Award
Stock Option (Right to Buy)
2024-10-04+50,000→ 50,000 totalExercise: $1.19Exp: 2034-10-04→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]These stock options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"). The shares underlying these stock options will vest immediately upon the Company's achievement of U.S. Food and Drug Administration clearance or approval of DrugSorb-ATR, subject to the Company's receipt of such clearance or approval prior to June 30, 2026 and the reporting person's continued service as of the applicable vesting date.
- [F2]These stock options were granted pursuant to the Plan. The shares underlying these stock options will vest immediately upon the Company's achievement of Health Canada clearance or approval of DrugSorb-ATR before, subject to the Company's receipt of such clearance or approval prior to June 30, 2026 and the reporting person's continued service as of the applicable vesting date.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001368151
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 9:00 PM ET
- Size
- 8.5 KB